🇨🇦 Canada Clinical Trials Database
Search 16,000+ clinical trials conducted in Canada. Access comprehensive trial data including phases, sponsors, outcomes, and locations from Health Canada & International Registries. Part of Pure Global AI's free database with 840,000+ trials worldwide.

What is the Canada clinical trials database?
The Canada clinical trials database contains over 16,000 clinical trials registered through Health Canada and international registries. It includes trials for drugs, medical devices, biologics, and behavioral interventions conducted in Canada.
How do I search for clinical trials in Canada?
Enter a disease name, drug name, sponsor, or trial ID in the search box above. You can filter results by phase, status, and intervention type.
What information is available for each trial?
Each trial listing includes: trial ID, study title, phase, status, sponsor, enrollment, start/end dates, disease/condition, intervention, primary outcomes, and location information.
Is this database free to use?
Yes, this database is completely free. Pure Global AI provides free access to clinical trial data to help researchers, patients, and companies find relevant clinical research in Canada.
How often is the database updated?
The database aggregates data from Health Canada and international registries and is updated regularly. The full database contains 840,000+ trials from 20+ registries worldwide.
What regulatory body oversees clinical trials in Canada?
Health Canada oversees clinical trials through the Clinical Trial Application (CTA) process. Research Ethics Boards (REBs) provide ethical oversight.
What types of trials are common in Canada?
Canada is known for high-quality clinical research, proximity to the US market, and competitive costs compared to US trials.
About This Database
This database provides free access to clinical trial data from Canada. Data is aggregated from Health Canada and international registries. Use this tool to research ongoing trials, find recruitment opportunities, analyze competitive landscape, and track drug/device development. Canada offers efficient regulatory pathways and is often included alongside US sites in North American trials.
